Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 78

1.

Memory CD4 T cell-mediated immunity against influenza A virus: more than a little helpful.

McKinstry KK, Dutton RW, Swain SL, Strutt TM.

Arch Immunol Ther Exp (Warsz). 2013 Oct;61(5):341-53. doi: 10.1007/s00005-013-0236-z. Epub 2013 May 25. Review. Erratum in: Arch Immunol Ther Exp (Warsz). 2013 Oct;61(5):355.

PMID:
23708562
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Principles underlying rational design of live attenuated influenza vaccines.

Jang YH, Seong BL.

Clin Exp Vaccine Res. 2012 Jul;1(1):35-49. doi: 10.7774/cevr.2012.1.1.35. Epub 2012 Jul 31.

PMID:
23596576
[PubMed]
Free PMC Article
3.

Influenza viruses with rearranged genomes as live-attenuated vaccines.

Pena L, Sutton T, Chockalingam A, Kumar S, Angel M, Shao H, Chen H, Li W, Perez DR.

J Virol. 2013 May;87(9):5118-27. doi: 10.1128/JVI.02490-12. Epub 2013 Feb 28.

PMID:
23449800
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Cross-protective immune responses elicited by live attenuated influenza vaccines.

Jang YH, Seong BL.

Yonsei Med J. 2013 Mar 1;54(2):271-82. doi: 10.3349/ymj.2013.54.2.271. Review.

PMID:
23364956
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Development of live-attenuated influenza vaccines against outbreaks of H5N1 influenza.

Zheng D, Yi Y, Chen Z.

Viruses. 2012 Dec 10;4(12):3589-605. doi: 10.3390/v4123589. Review.

PMID:
23223214
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Pseudotyped influenza A virus as a vaccine for the induction of heterotypic immunity.

Powell TJ, Silk JD, Sharps J, Fodor E, Townsend AR.

J Virol. 2012 Dec;86(24):13397-406. doi: 10.1128/JVI.01820-12. Epub 2012 Sep 26.

PMID:
23015719
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Oligomeric recombinant H5 HA1 vaccine produced in bacteria protects ferrets from homologous and heterologous wild-type H5N1 influenza challenge and controls viral loads better than subunit H5N1 vaccine by eliciting high-affinity antibodies.

Verma S, Dimitrova M, Munjal A, Fontana J, Crevar CJ, Carter DM, Ross TM, Khurana S, Golding H.

J Virol. 2012 Nov;86(22):12283-93. doi: 10.1128/JVI.01596-12. Epub 2012 Sep 5.

PMID:
22951833
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Comparative study of influenza virus replication in MDCK cells and in primary cells derived from adenoids and airway epithelium.

Ilyushina NA, Ikizler MR, Kawaoka Y, Rudenko LG, Treanor JJ, Subbarao K, Wright PF.

J Virol. 2012 Nov;86(21):11725-34. doi: 10.1128/JVI.01477-12. Epub 2012 Aug 22.

PMID:
22915797
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Long-term vaccine-induced heterologous protection against H5N1 influenza viruses in the ferret model.

Ducatez MF, Webb A, Crumpton JC, Webby RJ.

Influenza Other Respir Viruses. 2013 Jul;7(4):506-12. doi: 10.1111/j.1750-2659.2012.00423.x. Epub 2012 Aug 16.

PMID:
22897930
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Antibody pressure by a human monoclonal antibody targeting the 2009 pandemic H1N1 virus hemagglutinin drives the emergence of a virus with increased virulence in mice.

O'Donnell CD, Vogel L, Wright A, Das SR, Wrammert J, Li GM, McCausland M, Zheng NY, Yewdell JW, Ahmed R, Wilson PC, Subbarao K.

MBio. 2012 May 29;3(3). pii: e00120-12. doi: 10.1128/mBio.00120-12. Print 2012.

PMID:
22647789
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

The new temperature-sensitive mutation PA-F35S for developing recombinant avian live attenuated H5N1 influenza vaccine.

Zhang W, Tu J, Zhao Z, Chen H, Jin M.

Virol J. 2012 May 23;9:97. doi: 10.1186/1743-422X-9-97.

PMID:
22621130
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Cold-adapted pandemic 2009 H1N1 influenza virus live vaccine elicits cross-reactive immune responses against seasonal and H5 influenza A viruses.

Jang YH, Byun YH, Lee YJ, Lee YH, Lee KH, Seong BL.

J Virol. 2012 May;86(10):5953-8. doi: 10.1128/JVI.07149-11. Epub 2012 Mar 21.

PMID:
22438541
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

The contribution of systemic and pulmonary immune effectors to vaccine-induced protection from H5N1 influenza virus infection.

Lau YF, Wright AR, Subbarao K.

J Virol. 2012 May;86(9):5089-98. doi: 10.1128/JVI.07205-11. Epub 2012 Feb 29.

PMID:
22379093
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Polyvalent DNA vaccines expressing HA antigens of H5N1 influenza viruses with an optimized leader sequence elicit cross-protective antibody responses.

Wang S, Hackett A, Jia N, Zhang C, Zhang L, Parker C, Zhou A, Li J, Cao WC, Huang Z, Li Y, Lu S.

PLoS One. 2011;6(12):e28757. doi: 10.1371/journal.pone.0028757. Epub 2011 Dec 21.

PMID:
22205966
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

The multibasic cleavage site of the hemagglutinin of highly pathogenic A/Vietnam/1203/2004 (H5N1) avian influenza virus acts as a virulence factor in a host-specific manner in mammals.

Suguitan AL Jr, Matsuoka Y, Lau YF, Santos CP, Vogel L, Cheng LI, Orandle M, Subbarao K.

J Virol. 2012 Mar;86(5):2706-14. doi: 10.1128/JVI.05546-11. Epub 2011 Dec 28.

PMID:
22205751
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

The receptor binding specificity of the live attenuated influenza H2 and H6 vaccine viruses contributes to vaccine immunogenicity and protection in ferrets.

Chen Z, Zhou H, Kim L, Jin H.

J Virol. 2012 Mar;86(5):2780-6. doi: 10.1128/JVI.06219-11. Epub 2011 Dec 21.

PMID:
22190726
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Antibody breadth and protective efficacy are increased by vaccination with computationally optimized hemagglutinin but not with polyvalent hemagglutinin-based H5N1 virus-like particle vaccines.

Giles BM, Bissel SJ, Dealmeida DR, Wiley CA, Ross TM.

Clin Vaccine Immunol. 2012 Feb;19(2):128-39. doi: 10.1128/CVI.05533-11. Epub 2011 Dec 21.

PMID:
22190399
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Evaluation of the sublingual route for administration of influenza H5N1 virosomes in combination with the bacterial second messenger c-di-GMP.

Pedersen GK, Ebensen T, Gjeraker IH, Svindland S, Bredholt G, Guzmán CA, Cox RJ.

PLoS One. 2011;6(11):e26973. doi: 10.1371/journal.pone.0026973. Epub 2011 Nov 1.

PMID:
22069479
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Adaptation of high-growth influenza H5N1 vaccine virus in Vero cells: implications for pandemic preparedness.

Tseng YF, Hu AY, Huang ML, Yeh WZ, Weng TC, Chen YS, Chong P, Lee MS.

PLoS One. 2011;6(10):e24057. doi: 10.1371/journal.pone.0024057. Epub 2011 Oct 13.

PMID:
22022351
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Vaccination with drifted variants of avian H5 hemagglutinin protein elicits a broadened antibody response that is protective against challenge with homologous or drifted live H5 influenza virus.

Santiago FW, Fitzgerald T, Treanor JJ, Topham DJ.

Vaccine. 2011 Nov 8;29(48):8888-97. doi: 10.1016/j.vaccine.2011.09.069. Epub 2011 Sep 28.

PMID:
21963871
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk